Evidence map›Paper›PMID 37365035›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2023

[Advances in anticoagulant therapy for cirrhosis combined with atrial fibrillation].

J Y Ren, X T Li, M C Long, H Liu, N E Tang, R J Zheng, X B Lu

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J Y RenCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
X T LiCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
M C LongCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
H LiuCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
N E TangCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
R J ZhengCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
X B LuCenter for Infection-Liver Diseases, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Xinjiang Medical University · CN

Funding

National Natural Science Foundation of China 82060115
6 · The paper itself

Abstract

Relevant research in recent years has demonstrated that the atrial fibrillation occurrence rate is significantly higher in patients with cirrhosis. The most common indication for long-term anticoagulant therapy is chronic atrial fibrillation. The use of anticoagulant therapy greatly reduces the incidence rate of ischemic stroke. Patients with cirrhosis combined with atrial fibrillation have an elevated risk of bleeding and embolism during anticoagulant therapy due to cirrhotic coagulopathy. At the same time, the liver of such patients will go through varying levels of metabolism and elimination while consuming currently approved anticoagulant drugs, thereby increasing the complexity of anticoagulant therapy. This article summarizes the clinical studies on the risks and benefits of anticoagulant therapy in order to provide a reference for patients with cirrhosis combined with atrial fibrillation.

Indexed as

Atrial FibrillationStrokeAnticoagulantsHemorrhageHumansLiver CirrhosisRisk FactorsAnticoagulantsAnticoagulant therapyAtrial fibrillationLiver cirrhosis

Identifiers

PMID37365035
PMCPMC12813903
OpenAlexW4382182695

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.